From: Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital
Characteristic
N (%)
Male
210 (71.4%)
Female
84 (26.6%)
Mean age
62.9+/_11.3
Creatinine clearance
● More than 40 ml/min
220 (75%)
● Less than 40 ml/min
60 (20%)
RRT
14 (5%)
Mean duration of therapy
8.1+/_4.7 days